前列腺癌种植性动物模型概述(4)
[15] Yang M，Jiang P，Yamamoto N，et al.Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein[J].Prostate，2005，62(4)：374-379.
[16] Scatena C D，Hepner M A，Oei Y A，et al.Imaging of bioluminescent LNCaP-luc-M6 tumors：a new animal model for the study of metastatic human prostate cancer[J].Prostate，2004，59(3)：292-303.
[17] Adams J Y，Johnson M，Sato M，et al.Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and potical imaging[J].Nat Med，2002，8(8)：891-897.
[18]尤強，蔡华伟，庞富文，等.18F-NaF PET-CT显像技术辅助下的前列腺癌骨转移动物模型建立[J]，四川大学学报：医学版，2017，48(2)：276-281.
[19]詹以安，王共先，胡红林，等.β干扰素基因修饰的人骨髓间充质干细胞治疗前列腺癌小鼠移植瘤的实验研究[J].中华泌尿外科杂志，2012，33(6)：459-463.
[20] Yu Y，Zhang Q，Meng Q，et al.Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages[J].Oncotarget，2016，7(44)：71112-71122.
[21] Nakamizo A，Marini F，Amano T，et al.Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas[J].Cancer Res，2005，65(8)：3307-33l8.
[22] Jiwen Cheng，Keqin Yang，Qingyun Zhang，et al.The role of mesenchymal stem cells in promoting the transformation of androgen-dependent human prostate cancer cells into androgen-independent manner[J].Sci Rep，2016，6：16993.
[23] Cheng J，Ye H，Liu Z，Xu C，et al.Platelet-derived growth factor-BB accelerates prostate cancer growth by promoting the proliferation of mesenchymal stem cells[J].J Cell Biochem，2013，114(7)：1510-1518.
(收稿日期：2017-10-24), 百拇医药(邱月 王东 祝绍隆 尹心宝 焦方东 刘铭 王振宇 袁会阳)
[16] Scatena C D，Hepner M A，Oei Y A，et al.Imaging of bioluminescent LNCaP-luc-M6 tumors：a new animal model for the study of metastatic human prostate cancer[J].Prostate，2004，59(3)：292-303.
[17] Adams J Y，Johnson M，Sato M，et al.Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and potical imaging[J].Nat Med，2002，8(8)：891-897.
[18]尤強，蔡华伟，庞富文，等.18F-NaF PET-CT显像技术辅助下的前列腺癌骨转移动物模型建立[J]，四川大学学报：医学版，2017，48(2)：276-281.
[19]詹以安，王共先，胡红林，等.β干扰素基因修饰的人骨髓间充质干细胞治疗前列腺癌小鼠移植瘤的实验研究[J].中华泌尿外科杂志，2012，33(6)：459-463.
[20] Yu Y，Zhang Q，Meng Q，et al.Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages[J].Oncotarget，2016，7(44)：71112-71122.
[21] Nakamizo A，Marini F，Amano T，et al.Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas[J].Cancer Res，2005，65(8)：3307-33l8.
[22] Jiwen Cheng，Keqin Yang，Qingyun Zhang，et al.The role of mesenchymal stem cells in promoting the transformation of androgen-dependent human prostate cancer cells into androgen-independent manner[J].Sci Rep，2016，6：16993.
[23] Cheng J，Ye H，Liu Z，Xu C，et al.Platelet-derived growth factor-BB accelerates prostate cancer growth by promoting the proliferation of mesenchymal stem cells[J].J Cell Biochem，2013，114(7)：1510-1518.
(收稿日期：2017-10-24), 百拇医药(邱月 王东 祝绍隆 尹心宝 焦方东 刘铭 王振宇 袁会阳)